Compare Immunovant Inc. Common Stock (IMVT) vs UBS Group AG Registered Ordinary Shares (UBS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs UBS Group AG Registered Ordinary Shares — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while UBS Group AG Registered Ordinary Shares trades at $47.69 (market cap $144.63B). The key difference: UBS Group AG Registered Ordinary Shares is far larger — about 21.8× Immunovant Inc. Common Stock's market cap, and UBS Group AG Registered Ordinary Shares pays a 2.32% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and UBS Group AG Registered Ordinary Shares for 0 Days on average.
| IMVT | UBS | |
|---|---|---|
Market Cap | $6.62B | $144.63B |
Volume | 1,131,364 | 1,746,723 |
Sector | Health | Financials |
52-Week High | $44.96 | $55.72 |
52-Week Low | $17.03 | $36.41 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.72B | $311.50B |
Dividend Yield | — | 2.32% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About UBS Group AG Registered Ordinary Shares
UBS is a global financial services company focused on wealth management, investment banking, and asset management. It serves private, corporate, and institutional clients.
Read more on UBS →
